<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36540479</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Enterovirus-Human-Rhinovirus Infection Leading to Acute Respiratory Distress Syndrome: A Case Report.</ArticleTitle><Pagination><StartPage>e31615</StartPage><MedlinePgn>e31615</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e31615</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.31615</ELocationID><Abstract><AbstractText>Enterovirus-human-rhinovirus (EV-HRV) is best known to cause the "common cold" and asthma exacerbations. Simple bronchitis and community-acquired pneumonia related to EV-HRV are also well documented. Scattered reports of rhinovirus causing acute respiratory distress syndrome (ARDS) have been published, yet the causality between recent SARS-CoV-2 pneumonia and severe ARDS secondary to EV-HRV has not been well defined. This case presents a 67-year-old male who was unvaccinated against SARS-CoV-2 with a past medical history of chronic obstructive pulmonary disease, who recently experienced a mild-to-moderate case of SARS-CoV-2 pneumonia, which was treated with dexamethasone and remdesivir. He was discharged to an inpatient psychiatric facility on as-needed oxygen via nasal cannula. Three weeks later, he experienced an episode of presyncope and was readmitted to the hospital. He then began to require increasing levels of supplemental oxygen via a high-flow nasal cannula. A real-time polymerase chain reaction respiratory pathogen panel was positive for EV-HRV. Computed tomography of the chest revealed extensive ground-glass opacities. Further workup for bacterial and fungal pneumonia was negative. Repeat SARS-CoV-2 testing was also negative. He required several days of supplemental oxygen via a high-flow nasal cannula. He received a short course of broad-spectrum antibiotics and a 10-day course of high-dose dexamethasone. Ultimately, he fully recovered, did not require further supplemental oxygen, and was discharged on room air.</AbstractText><CopyrightInformation>Copyright © 2022, Cecchini et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cecchini</LastName><ForeName>Arthur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Othman</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Kirandeep</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, East Tennessee State University Quillen College of Medicine, Johnson City, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Austin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, St. Bernards Healthcare, Jonesboro, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchini</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute hypoxemic respiratory failure</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome</Keyword><Keyword MajorTopicYN="N">acute respiratory distress syndrome (ards)</Keyword><Keyword MajorTopicYN="N">dexamethasone</Keyword><Keyword MajorTopicYN="N">ground-glass opacities</Keyword><Keyword MajorTopicYN="N">high-flow nasal cannula</Keyword><Keyword MajorTopicYN="N">high-flow nasal cannula (hfnc)</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword><Keyword MajorTopicYN="N">sars-cov-2</Keyword><Keyword MajorTopicYN="N">secondary pneumonia</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>21</Day><Hour>2</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36540479</ArticleId><ArticleId IdType="pmc">PMC9757646</ArticleId><ArticleId IdType="doi">10.7759/cureus.31615</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rhinovirus - from bench to bedside. To KK, Yip CC, Yuen KY. J Formos Med Assoc. 2017;116:496–504.</Citation><ArticleIdList><ArticleId IdType="pubmed">28495415</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinovirus infections and their roles in asthma: etiology and exacerbations. Jackson DJ, Gern JE. J Allergy Clin Immunol Pract. 2022;10:673–681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10314805</ArticleId><ArticleId IdType="pubmed">35074599</ArticleId></ArticleIdList></Reference><Reference><Citation>Enterovirus-human rhinovirus: a rare cause of acute respiratory distress syndrome. Soni P, Rai A, Aggarwal N, Kamholz S, Yoon T, Kupfer Y. J Investig Med High Impact Case Rep. 2017;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5588805</ArticleId><ArticleId IdType="pubmed">28904980</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinovirus-induced rapidly progressing acute respiratory distress syndrome in an immunocompetent host. Ngu S, Pervaiz S, Avula A, Chalhoub M. Cureus. 2019;11:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6443533</ArticleId><ArticleId IdType="pubmed">30989006</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute respiratory distress syndrome secondary to enterovirus-human-rhinovirus infection in an adult. Hamid K, Ali M, Devasahayam J. Cureus. 2022;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9247263</ArticleId><ArticleId IdType="pubmed">35784975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinovirus-associated severe acute respiratory distress syndrome (ARDS) managed with airway pressure release ventilation (APRV) Ayala C, Baiu I, Owyang C, Forrester JD, Spain D. Trauma Surg Acute Care Open. 2019;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6660799</ArticleId><ArticleId IdType="pubmed">31392279</ArticleId></ArticleIdList></Reference><Reference><Citation>Human rhinovirus infection during naturally occurring COPD exacerbations. George SN, Garcha DS, Mackay AJ, et al. Eur Respir J. 2014;44:87–96.</Citation><ArticleIdList><ArticleId IdType="pubmed">24627537</ArticleId></ArticleIdList></Reference><Reference><Citation>Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Mallia P, Message SD, Gielen V, et al. Am J Respir Crit Care Med. 2011;183:734–742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3081284</ArticleId><ArticleId IdType="pubmed">20889904</ArticleId></ArticleIdList></Reference><Reference><Citation>Community-acquired pneumonia requiring hospitalization among U.S. adults. Jain S, Self WH, Wunderink RG, et al. N Engl J Med. 2015;373:415–427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728150</ArticleId><ArticleId IdType="pubmed">26172429</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute respiratory distress syndrome. Meyer NJ, Gattinoni L, Calfee CS. Lancet. 2021;398:622–637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248927</ArticleId><ArticleId IdType="pubmed">34217425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung inhomogeneity in patients with acute respiratory distress syndrome. Cressoni M, Cadringher P, Chiurazzi C, et al. Am J Respir Crit Care Med. 2014;189:149–158.</Citation><ArticleIdList><ArticleId IdType="pubmed">24261322</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Villar J, Ferrando C, Martínez D, et al. Lancet Respir Med. 2020;8:267–276.</Citation><ArticleIdList><ArticleId IdType="pubmed">32043986</ArticleId></ArticleIdList></Reference><Reference><Citation>Low-tidal-volume ventilation in the acute respiratory distress syndrome. Malhotra A. N Engl J Med. 2007;357:1113–1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2287190</ArticleId><ArticleId IdType="pubmed">17855672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>